Semra Paydaş

32PUBLICATIONS

187CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Molecular targetsInorganic materials (incl. nanomaterials)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (32)

Sort by Publication Date:

|Jun 26, 2026

Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort-A Turkish Oncology Group (TOG) Study.

|May 27, 2026

Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study.

|Mar 28, 2026

Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG).

Bengü Dursun, Şendağ Yaslıkaya, Serhat Sekmek

|Feb 27, 2026

Prognostic Significance of Immune Checkpoint Markers in Prognosis of Grade 3 Endometrioid Carcinoma.

Emine Kilic Bagir, Umran Kucukgoz Gulec, Semra Paydas

|Oct 29, 2025

Clinical Evaluation of Patients Using Antineoplastic Chemotherapeutic Agents with Body Composition Monitor Measurement Before and at 3 Months of Treatment.

Mehmet Turan Ozer, Ertugrul Bayram, Saime Paydas

|Sep 13, 2024

A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients.

Özgür Mehtap, Tayfur Toptas, Mehmet S Dal

Pageof 6

Frequent Collaborators

Mahmut Büyükşimşek

Ali Oğul

Ertugrul Bayram

Özkan Alan

Umran Kucukgoz Gulec

Emine Kilic Bagir

Atakan Demir

Derya Gümürdülü

Abdullah Evren Yetişir

3 joint publications

Ahmet Baris Guzel

Frequent Collaborators

Mahmut Büyükşimşek

Ali Oğul

Ertugrul Bayram

Özkan Alan